Sign Up Today and Learn More About Caresyntax Stock
Invest in or calculate the value of your shares in Caresyntax or other pre-IPO companies through EquityZen's platform.
Caresyntax Stock
Caresyntax is a vendor neutral data-driven surgery platform that makes surgery smarter by reducing variability and improving efficency.
About Caresyntax Stock
Founded
2013
Headquarters
Boston, MA, US
Notable Investor
BlackRock
Industries
Caresyntax is a digital surgery platform that enables OR teams to predict and improve surgical performance. Its enterprise-grade digital surgery platform delivers insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around the OR. Caresyntax insights help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide, has supported more than 30,000 surgeons, and improved care for more than 2 million patients.
Caresyntax Press Mentions
Stay in the know about the latest news on Caresyntax
Rescale and Caresyntax Expand their Collaboration to Provide a Scalable Platform for AI-Powered Simulation and ...
prnewswire • Apr 06, 2024
Caresyntax announces launch of novel Real World Evidence (RWE) program and software portfolio of digital catalysts for commercial acceleration of Medtech partners
businesswire • Jan 08, 2024
Caresyntax Announces Strategic Collaboration with AAICO to expand AI-based solutions in healthcare
prnewswire • Dec 07, 2023
Caresyntax and ProAssurance join hands for surgical intelligence
seekingalpha • Jun 19, 2023
Caresyntax brings Series C funding to $130M
massdevice • Sep 18, 2021
Investors in Caresyntax
Discover investors in Caresyntax stock and explore their portfolio companies
Caresyntax Management
Leadership team at Caresyntax
Co-Founder and CEO
Dennis Kogan
Chief Financial Officer
Claire Masterson
Join now and verify your accreditation status to gain access to:
- Caresyntax current valuation
- Caresyntax stock price
- Available deals in Caresyntax and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Caresyntax stock?
Accredited investors can buy pre-IPO stock in companies like Caresyntax through EquityZen funds. These investments are made available by existing Caresyntax shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Caresyntax stock?
Shareholders can sell their Caresyntax stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
